Press

ISPOR Press Pass Information

ISPOR—the professional society for health economics and outcomes research—invites credentialed journalists to cover its scientific conferences and Summits. Journalists are required to complete an application form, and ISPOR will grant press passes based on a formal review and vetting of submitted materials.

Press passes are available for journalists and correspondents representing newspapers, news programs, industry newsletters, and business publications that operate within the scope of ISPOR's mission and objectives. Some examples include, but are not limited to:

PM360 | AJMC | The Gold Sheet  |  PharmAsia News  |  The Gray Sheet  |  The Pink Sheet  |  The Silver Sheet  |  BioPharm Insight  |  Health News Daily |  Politico Pro Healthcare  |  Pharmaceutical Approvals Monthly  |  APM Health Europe  |  Medtech Insight  |  Health 2.0 Latin America

ISPOR Press Pass Application Deadline for the ISPOR-FDA Summit 2020 is March 24, 2020.

Apply for a Press Pass here

ISPOR will contact you to confirm your request and to provide further information.

Members of the media are strongly encouraged to send ISPOR examples of their coverage after the Summit. We ask that the Summit name, date, and location be appropriately credited (eg, "from ISPOR-FDA Summit 2020 held March 31, 2020 in Silver Spring, MD, USA") in all media coverage, including print news stories, e-newsletters, web postings, blogs, and/or video coverage. All print, broadcast, and electronic media clips/write-ups, etc, should be sent to ISPOR Communications at press@ispor.org. ISPOR does not share, rent, or distribute media registration information.

Summit attendees must gain approval from a speaker prior to quoting or publishing that individual's scientific results. Members of the press must identify themselves as such before questioning speakers and Summit attendees if using the information in a professional capacity.

ISPOR Legal Disclaimer

ISPOR—the professional society for health economics and outcomes research ("ISPOR" or "Society")—is providing information and services on the Internet through its website as a benefit and service in furtherance of its nonprofit and tax exempt status under Section 501(c)(3) of the Internal Revenue Code. ISPOR does not endorse, approve, guarantee, or certify that any information posted by ISPOR or third parties is accurate, complete, timely, or effective. Use of such information is entirely voluntary and reliance on it should only be undertaken after an independent review of it by qualified experts.

Any posting, electronic or related discussions, or other conduct or activities must comply with all applicable laws and ISPOR standards, policies, and procedures. Although the ISPOR website may include links providing direct access to other Internet sites, the Society has not participated in the development of those other sites and does not exert any editorial or other control over those other sites.

The ISPOR website is created and controlled by ISPOR in New Jersey, USA. As such, the laws of New Jersey shall govern these disclaimers and terms and conditions of use and any conflict that may arise in connection with this website without reference to any principles of conflicts of laws. Jurisdiction and venue for all such conflicts arising in connection with this website shall be in the state or federal courts of New Jersey.

The ISPOR logo is the property of ISPOR—the professional society for health economics and outcomes research—and cannot be used without the expressed written consent of ISPOR.

Any questions should be directed to ISPOR Communications at press@ispor.org

FDA Note to Reporters:

Accessing the public meetings held at the White Oak Campus does not require an FDA escort. However, when public meetings end, it is important to know that non-FDA personnel are required to leave the premises at the conclusion of the event. Reporters should not plan on filing their stories from the Campus after the meeting, for example. If you are a reporter and you feel you will need to stay on Campus for any reason after a meeting has concluded, you are encouraged to contact one of the Agency’s Press Officers

Also, please remember to sign the press registration sheet before entering a meeting room. The FDA asks that you not approach workshop participants while their meetings are in progress. Please refrain from any flash photography or TV camera lights while the meetings are in session. Contact an FDA Press Officer to arrange for an interview with any FDA speakers presenting at an event.

Source: FDA Website